1-3 of 3
Pamela Ihonor
Close
Sort by
Journal Articles

Mimetic Peptide to CDK Inhibitor p16 INK4a Induces Cell Death In Mantle Cell Lymphoma Cells: A New Strategy to Eradicate Minimal Residual Disease

Hongtao Liu, MD, PhD, Greg Koval, MS, Greg Malnassy, MS, Pamela Ihonor, MS, Hui Liu, MS, Roger Luo, PhD, Amittha Wickrema, PhD, Steven Dowdy, PhD, Michael Thirman, MD, Koen van Besien, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 3921.
https://doi.org/10.1182/blood.V116.21.3921.3921
Published: 2010
Journal Articles

Combination of a MEK Inhibitor, AZD6244, and Dual PI3K/mTOR Inhibitor, NVP-BEZ235: An Effective Therapeutic Strategy for Acute Myeloid Leukemia

Hongtao Liu, MD, PhD, Ernesto Diaz-Flores, PhD, Xavier Poiré, MD, Olatoyosi Odenike, MD, Greg Koval, MS, Greg Malnassy, MS, Pamela Ihonor, MS, Yanming Zhang, MD, Michelle M. Le Beau, PhD, Kevin Shannon, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 3978.
https://doi.org/10.1182/blood.V116.21.3978.3978
Published: 2010
Journal Articles

Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).

Olatoyosi Odenike, Emily Curran, Neil Iyengar, Leslie Popplewell, Mark Kirschbaum, Harry P Erba, Margaret Green, Xavier Poiré, Pamela Ihonor, Ernesto Diaz-Flores, Kevin Shannon, Ehab Atallah, James L Wade, III, Maria Perdekamp, Sreenivasa Nattam, Sachdev P. Thomas, Scott E. Smith, L. Austin Doyle, Elizabeth Shima Rich, Richard A. Larson, Wendy Stock
Journal: Blood
Blood (2009) 114 (22): 2081.
https://doi.org/10.1182/blood.V114.22.2081.2081
Published: 2009